← Every applicant
Accord Biopharma Inc. FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| IMMGOLISNew drugMay 15, 2026INJECTION, SOLUTION |
| ENNUMONew drugMay 7, 2026INJECTABLE, SUBCUTANEOUS |
| FILKRINew drugJan 15, 2026INJECTABLE, INJECTION |
| OSVYRTINew drugOct 29, 2025INJECTABLE, SUBCUTANEOUS |
| IMULDOSANew drugOct 10, 2024INJECTABLE, INTRAVENOUS |
| HERCESSINew drugApr 25, 2024INJECTABLE, INJECTION |